Photo of Caitlyn Doerr

Caitlyn is an Associate in Wiggin and Dana’s Litigation Department in the New Haven office.

Recent merger settlements further confirm that merger remedies are back and indicate the healthcare industry remains a priority for antitrust enforcers.

In July, we published an alert regarding the resolutions of two merger investigations initiated by the Federal Trade Commission (FTC) and the Department of Justice Antitrust Division (DOJ).[1] We observed a key shift in enforcement policies under the new Trump administration based on

Read More Merger Remedies Are Back in Play: Recent Developments

The Federal Trade Commission (FTC) recently announced two important changes affecting how it will address noncompetition agreements and covenants. One is the dismissal by the FTC of its noncompete rule, thus ending the agency’s attempt to seek judicial review of two decisions that held both the trade regulation process as well as the substance of the rule flawed. The second is the initiative by the

Read More The FTC Intends to Challenge Non-Competes on a Case by Case Basis